# MyoKardia, Inc.

MyoKardia, Inc. is a company headquartered in Brisbane, CA, United States.

## Company overview

- **Legal name:** MyoKardia, Inc.
- **Former names in filing history:** MyoKardia Inc (2012-07-05 to 2020-02-27)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Brisbane, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001552451

## About

MyoKardia, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001552451, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-02-27, it reported annual revenue of USD 0; net income of USD -276,213,000; total assets of USD 456,094,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$276.2M (USD -276,213,000)
- **Total assets:** $456.1M (USD 456,094,000)
- **Cash and equivalents:** $101.4M (USD 101,436,000)
- **Operating cash flow:** -$241.8M (USD -241,769,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $33.6M (USD 33,558,000)
- **Net income:** -$67.7M (USD -67,698,000)
- **Total assets:** $407.3M (USD 407,253,000)
- **Cash and equivalents:** $246.1M (USD 246,122,000)
- **Operating cash flow:** -$64.8M (USD -64,815,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$46.0M (USD -45,952,000)
- **Total assets:** $282.8M (USD 282,808,000)
- **Cash and equivalents:** $224.6M (USD 224,571,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$13.2M (USD -13,152,000)
- **Total assets:** $201.3M (USD 201,306,000)
- **Cash and equivalents:** $135.8M (USD 135,797,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form SC 13G — filed 2020-11-27
- Form 8-K — filed 2020-11-17 — period 2020-11-17 — 8-K
- Form 10-Q — filed 2020-11-05 — period 2020-09-30 — 10-Q
- Form 8-K — filed 2020-11-05 — period 2020-11-05 — 8-K
- Form 8-K — filed 2020-10-05 — period 2020-10-03 — 8-K
- Form 10-Q — filed 2020-08-04 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-08-04 — period 2020-08-04 — 8-K
- Form 8-K — filed 2020-06-24 — period 2020-06-18 — 8-K
- Form 8-K — filed 2020-05-14 — period 2020-05-12 — 8-K
- Form 8-K — filed 2020-05-11 — period 2020-05-11 — 8-K
- Form 10-Q — filed 2020-05-06 — period 2020-03-31 — 10-Q
- Form 8-K — filed 2020-05-06 — period 2020-05-06 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/myokardia-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology